Luke Evnin - Net Worth and Insider Trading

Luke Evnin Net Worth

The estimated net worth of Luke Evnin is at least $39 Million dollars as of 2026-08-10. Luke Evnin is the Director of Pacira BioSciences Inc and owns about 824,255 shares of Pacira BioSciences Inc (PCRX) stock worth over $20 Million. Luke Evnin is the Director, 10% Owner of Harpoon Therapeutics Inc and owns about 452,443 shares of Harpoon Therapeutics Inc (HARP) stock worth over $10 Million. Luke Evnin is also the 10% Owner of Rigel Pharmaceuticals Inc and owns about 168,707 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $7 Million. Besides these, Luke Evnin also holds Conatus Pharmaceuticals Inc (CNAT) , Oncorus Inc (ONCR) , Werewolf Therapeutics Inc (HOWL) . Details can be seen in Luke Evnin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Luke Evnin has not made any transactions after 2026-07-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Luke Evnin

Are these stocks worth buying? — GuruFocus analysis for each holding

- GF

PCRX Pacira BioSciences Inc

54% of holdings · $20.5M

HARP Harpoon Therapeutics Inc

27% of holdings · $10.4M

RIGL Rigel Pharmaceuticals Inc

18% of holdings · $6.8M

1% of holdings · $314K

HOWL Werewolf Therapeutics Inc

0% of holdings · $43K

Luke Evnin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Luke Evnin owns 36 companies in total, including Turmeric Acquisition Corp (TMPMU) , Oncorus Inc (ONCR) , and Dyne Therapeutics Inc (DYN) among others .

Click here to see the complete history of Luke Evnin’s form 4 insider trades.

Insider Ownership Summary of Luke Evnin

Ticker	Company	Transaction Date	Type of Owner
TMPMU	Turmeric Acquisition Corp	2020-10-15	Chief Executive Officer
ONCR	Oncorus Inc	2020-10-06	director & 10 percent owner
DYN	Dyne Therapeutics Inc	2020-09-16	10 percent owner
		2020-07-23	10 percent owner
		2020-06-18	10 percent owner
		2019-02-12	director & 10 percent owner
		2019-02-13	10 percent owner
		2016-03-02	director & 10 percent owner
		2017-10-04	10 percent owner
		2008-06-15	10 percent owner
		2015-10-14	10 percent owner
		2015-07-21	10 percent owner
		2014-05-07	director
		2014-04-22	10 percent owner
		2014-03-10	10 percent owner
		2013-05-30	10 percent owner
		2013-07-24	10 percent owner
		2013-06-13	director & 10 percent owner
		2012-08-11	10 percent owner
		2012-01-26	other: Former 10% stockholder
		2011-10-27	10 percent owner
		2007-08-03	other: See explanation below
		2010-09-30	10 percent owner
		2010-03-11	10 percent owner
		2010-01-27	director & 10 percent owner
		2009-11-05	10 percent owner
		2004-07-28	10 percent owner
		2006-12-19	10 percent owner
		2003-12-17	10 percent owner
		2004-09-01	10 percent owner
		2004-03-10	10 percent owner
		2004-02-09	10 percent owner
		2021-10-28	10 percent owner
		2026-07-07	director
		2020-10-15	Chief Executive Officer
		2026-01-08	10 percent owner

Luke Evnin Latest Holdings Summary

Luke Evnin currently owns a total of 6 stocks. Among these stocks, Luke Evnin owns 824,255 shares of Pacira BioSciences Inc (PCRX) as of June 13, 2013, with a value of $20 Million and a weighting of 52.17%. Luke Evnin owns 452,443 shares of Harpoon Therapeutics Inc (HARP) as of February 12, 2019, with a value of $10 Million and a weighting of 26.97%. Luke Evnin also owns 168,707 shares of Rigel Pharmaceuticals Inc (RIGL) as of September 1, 2004, with a value of $7 Million and a weighting of 18.21%. The other 3 stocks Conatus Pharmaceuticals Inc (CNAT) , Oncorus Inc (ONCR) , Werewolf Therapeutics Inc (HOWL) have a combined weighting of 2.65% among all his current holdings.

Latest Holdings of Luke Evnin

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PCRX	Pacira BioSciences Inc	2013-06-13	824,255	24.43	20,136,550
HARP	Harpoon Therapeutics Inc	2019-02-12	452,443	23.01	10,410,713
RIGL	Rigel Pharmaceuticals Inc	2004-09-01	168,707	41.66	7,028,334
CNAT	Conatus Pharmaceuticals Inc	2013-07-30	1,192,080	0.56	667,565
ONCR	Oncorus Inc	2020-10-06	2,492,843	0.13	314,098
HOWL	Werewolf Therapeutics Inc	2026-07-07	107,429	0.38	41,038

Holding Weightings of Luke Evnin

Luke Evnin Form 4 Trading Tracker

According to the SEC Form 4 filings, Luke Evnin has made a total of 0 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years. The most-recent trade in Pacira BioSciences Inc is the sale of 22,746 shares on June 13, 2013, which brought Luke Evnin around $683,972.

According to the SEC Form 4 filings, Luke Evnin has made a total of 0 transactions in Harpoon Therapeutics Inc (HARP) over the past 5 years. The most-recent trade in Harpoon Therapeutics Inc is the acquisition of 25,000 shares on February 12, 2019, which cost Luke Evnin around $4 Million.

According to the SEC Form 4 filings, Luke Evnin has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 8,585 shares on September 1, 2004, which brought Luke Evnin around $2 Million.

More details on Luke Evnin's insider transactions can be found in the Insider Trading History of Luke Evnin table.

Insider Trading History of Luke Evnin

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Luke Evnin Trading Performance

GuruFocus tracks the stock performance after each of Luke Evnin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Luke Evnin is 32.21%. GuruFocus also compares Luke Evnin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Luke Evnin within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Luke Evnin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Luke Evnin

Average Return

Average return per transaction

Outperforming Transactions

4 out of 6 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	5.24
Relative Return to S&P 500(%)	3.87

Get the full picture on these stocks

See GF Score, valuation, financials, and warning signs for every stock Luke Evnin owns.

- PCRX - HARP - RIGL - ONCR - HOWL

View PCRX Analysis

Luke Evnin Ownership Network

Ownership Network List of Luke Evnin

No Data

Ownership Network Relation of Luke Evnin

Luke Evnin Owned Company Details

What does Turmeric Acquisition Corp do?

Who are the key executives at Turmeric Acquisition Corp?

Luke Evnin is the Chief Executive Officer of Turmeric Acquisition Corp. Other key executives at Turmeric Acquisition Corp include Chief Financial Officer Edward Hurwitz , President Todd Foley , and 10 percent owner Turmeric Management, Llc .

Turmeric Acquisition Corp (TMPMU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Turmeric Acquisition Corp (TMPMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turmeric Acquisition Corp (TMPMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turmeric Acquisition Corp (TMPMU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Turmeric Acquisition Corp Insider Transactions

No Available Data

What does Oncorus Inc do?

Who are the key executives at Oncorus Inc?

Luke Evnin is the director & 10 percent owner of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .

Oncorus Inc (ONCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oncorus Inc Insider Transactions

No Available Data

What does Dyne Therapeutics Inc do?

Who are the key executives at Dyne Therapeutics Inc?

Luke Evnin is the 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include director & 10 percent owner Dirk Kersten , director & 10 percent owner Jason P Rhodes , and Chief Financial Officer Erick Lucera .

Dyne Therapeutics Inc (DYN) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 1,876,050 shares made by Dirk Kersten , a net purchase of 77,851 shares made by John Cox , and a net sale of 3,102,817 shares made by Jason P Rhodes .

In summary, during the past 3 months, insiders sold 2,172,311 shares of Dyne Therapeutics Inc (DYN) in total and bought 9,000 shares, with a net sale of 2,163,311 shares. During the past 18 months, 5,031,129 shares of Dyne Therapeutics Inc (DYN) were sold and 116,000 shares were bought by its insiders, resulting in a net sale of 4,915,129 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dyne Therapeutics Inc Insider Transactions

No Available Data

What does ITeos Therapeutics Inc do?

Who are the key executives at ITeos Therapeutics Inc?

Luke Evnin is the 10 percent owner of ITeos Therapeutics Inc. Other key executives at ITeos Therapeutics Inc include director & Chief Executive Officer Michel Detheux , director & 10 percent owner Ansbert Gadicke , and 10 percent owner Mpm Bioventures 2018, L.p. .

ITeos Therapeutics Inc (ITOS) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in ITeos Therapeutics Inc (ITOS). Other recent insider transactions involving ITeos Therapeutics Inc (ITOS) include a net sale of 261,412 shares made by Michel Detheux , a net purchase of 4,958,978 shares made by Ecor1 Capital, Llc , and a net sale of 1,031,931 shares made by Ansbert Gadicke .

In summary, during the past 3 months, insiders sold 0 shares of ITeos Therapeutics Inc (ITOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,668,407 shares of ITeos Therapeutics Inc (ITOS) were sold and 4,958,978 shares were bought by its insiders, resulting in a net purchase of 2,290,571 shares.

ITeos Therapeutics Inc (ITOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

ITeos Therapeutics Inc Insider Transactions

No Available Data

What does Repare Therapeutics Inc do?

Who are the key executives at Repare Therapeutics Inc?

Luke Evnin is the 10 percent owner of Repare Therapeutics Inc. Other key executives at Repare Therapeutics Inc include SVP & Finance and CAO Alves Sandra Isabelle Barros , EVP & Chief Medical Officer Maria Koehler , and EVP & Chief Science Officer Michael Zinda .

Repare Therapeutics Inc (RPTX) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 21,179 shares made by Lloyd Mitchell Segal , a net sale of 6,884 shares made by Steve Forte , and a net sale of 5,611 shares made by Michael Zinda .

In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,270 shares of Repare Therapeutics Inc (RPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,270 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Repare Therapeutics Inc Insider Transactions

No Available Data

What does Harpoon Therapeutics Inc do?

Who are the key executives at Harpoon Therapeutics Inc?

Luke Evnin is the director & 10 percent owner of Harpoon Therapeutics Inc. Other key executives at Harpoon Therapeutics Inc include 10 percent owner Vijay K Lathi , Chief Medical Officer Luke Nathaniel Walker , and Principal Fin. & Acctng Ofc. Frank J Lanza .

Harpoon Therapeutics Inc (HARP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Harpoon Therapeutics Inc (HARP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harpoon Therapeutics Inc (HARP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Harpoon Therapeutics Inc (HARP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Harpoon Therapeutics Inc Insider Transactions

No Available Data

What does TCR2 Therapeutics Inc do?

Who are the key executives at TCR2 Therapeutics Inc?

Luke Evnin is the 10 percent owner of TCR2 Therapeutics Inc. Other key executives at TCR2 Therapeutics Inc include 10 percent owner Kevin Tang , director & 10 percent owner Ansbert Gadicke , and 10 percent owner Mpm Asset Management Llc .

TCR2 Therapeutics Inc (TCRR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TCR2 Therapeutics Inc (TCRR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TCR2 Therapeutics Inc (TCRR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TCR2 Therapeutics Inc (TCRR)'s detailed insider trading history can be found in Insider Trading Tracker table.

TCR2 Therapeutics Inc Insider Transactions

No Available Data

What does Syndax Pharmaceuticals Inc do?

Who are the key executives at Syndax Pharmaceuticals Inc?

Luke Evnin is the director & 10 percent owner of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include director & Chief Executive Officer Michael A Metzger , Head of R&D & CMO Botwood Nicholas A.j. , and Chief Financial Officer Keith A. Goldan .

Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 236,448 shares made by Michael A Metzger , a net sale of 7,965 shares made by Keith A. Goldan , and a net sale of 53,750 shares made by Botwood Nicholas A.j. .

In summary, during the past 3 months, insiders sold 105,914 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 105,914 shares. During the past 18 months, 367,528 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 26,765 shares were bought by its insiders, resulting in a net sale of 340,763 shares.

Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Syndax Pharmaceuticals Inc Insider Transactions

No Available Data

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Luke Evnin is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Corporate Controller & CAO Christopher Paul German , CFO and Treasurer Hunter C Smith , and Chief Human Resources Officer Pamela J. Cramer .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 83,163 shares made by Pamela J. Cramer , a net sale of 62,413 shares made by Joseph Shulman , and a net sale of 119,523 shares made by Hunter C Smith .

In summary, during the past 3 months, insiders sold 41,643 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 41,643 shares. During the past 18 months, 550,753 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 550,753 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

What does Radius Health Inc do?

Who are the key executives at Radius Health Inc?

Luke Evnin is the 10 percent owner of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Senior Vice President Elizabeth Messersmith , and Vice President & Sales Danielle Holtschlag .

Radius Health Inc (RDUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Radius Health Inc Insider Transactions

No Available Data

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Luke Evnin is the 10 percent owner of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include Chief Medical Officer Mittie Doyle , Interim CFO Christopher Ryan Sullivan , and Chief Legal Officer Paul Varki .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net sale of 149,158 shares made by Mittie Doyle , a net sale of 98,480 shares made by Christopher Ryan Sullivan , and a net sale of 75,063 shares made by Paul Varki .

In summary, during the past 3 months, insiders sold 10,783 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 10,783 shares. During the past 18 months, 337,235 shares of Avalo Therapeutics Inc (AVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 337,235 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avalo Therapeutics Inc Insider Transactions

No Available Data

What does Chiasma Inc do?

Who are the key executives at Chiasma Inc?

Luke Evnin is the 10 percent owner of Chiasma Inc. Other key executives at Chiasma Inc include director & Chief Executive Officer Raj Kannan , EVP & Chief Commerical Officer Anand Varadan , and President Mark J. Fitzpatrick .

Chiasma Inc (CHMA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Chiasma Inc (CHMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chiasma Inc (CHMA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chiasma Inc (CHMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chiasma Inc Insider Transactions

No Available Data

What does Reshape Lifesciences Inc do?

Who are the key executives at Reshape Lifesciences Inc?

Luke Evnin is the director of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , President and CEO Barton P. Bandy , and director & Chairman & President and CEO Dan W Gladney .

Reshape Lifesciences Inc (RSLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reshape Lifesciences Inc Insider Transactions

No Available Data

What does TriVascular Technologies Inc do?

Who are the key executives at TriVascular Technologies Inc?

Luke Evnin is the 10 percent owner of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include Chief Technology Officer Michael V. Chobotov , VP Global Sales and Marketing Vivek K Jayaraman , and 10 percent owner New Enterprise Associates 12, Limited Partnership .

TriVascular Technologies Inc (TRIV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriVascular Technologies Inc Insider Transactions

No Available Data

What does Aratana Therapeutics Inc do?

Who are the key executives at Aratana Therapeutics Inc?

Luke Evnin is the 10 percent owner of Aratana Therapeutics Inc. Other key executives at Aratana Therapeutics Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .

Aratana Therapeutics Inc (PETX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aratana Therapeutics Inc (PETX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aratana Therapeutics Inc (PETX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aratana Therapeutics Inc (PETX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aratana Therapeutics Inc Insider Transactions

No Available Data

What does Epizyme Inc do?

Who are the key executives at Epizyme Inc?

Luke Evnin is the 10 percent owner of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .

Epizyme Inc (EPZM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Epizyme Inc Insider Transactions

No Available Data

What does Histogen Inc do?

Who are the key executives at Histogen Inc?

Luke Evnin is the 10 percent owner of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .

Histogen Inc (HSTOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Histogen Inc (HSTOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Histogen Inc Insider Transactions

No Available Data

What does Pacira BioSciences Inc do?

Who are the key executives at Pacira BioSciences Inc?

Luke Evnin is the director & 10 percent owner of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Executive Director & Accounting Lauren Bullaro Riker , CAO and General Counsel Kristen Marie Williams , and Chief Financial Officer Shawn Cross .

Pacira BioSciences Inc (PCRX) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Pacira BioSciences Inc (PCRX). Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 62,060 shares made by Shawn Cross , a net sale of 17,109 shares made by Lauren Bullaro Riker , and a net sale of 37,772 shares made by Kristen Marie Williams .

In summary, during the past 3 months, insiders sold 16,374 shares of Pacira BioSciences Inc (PCRX) in total and bought 0 shares, with a net sale of 16,374 shares. During the past 18 months, 131,928 shares of Pacira BioSciences Inc (PCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 131,928 shares.

Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pacira BioSciences Inc Insider Transactions

No Available Data

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

Luke Evnin is the 10 percent owner of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and Chief Commercial Officer Edward P. Jordan .

Humanigen Inc (HGENQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Humanigen Inc Insider Transactions

No Available Data

What does Verastem Inc do?

Who are the key executives at Verastem Inc?

Luke Evnin is the other: Former 10% stockholder of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Vice President of Finance Daniel Calkins , and Chief Financial Officer Robert E. Gagnon .

Verastem Inc (VSTM) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 145,568 shares made by Dan Paterson , a net sale of 24,659 shares made by Daniel Calkins , and a net sale of 2,366 shares made by Brian M Stuglik .

In summary, during the past 3 months, insiders sold 26,262 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 26,262 shares. During the past 18 months, 196,858 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,858 shares.

Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verastem Inc Insider Transactions

No Available Data

What does EPIRUS Biopharmaceuticals Inc do?

Who are the key executives at EPIRUS Biopharmaceuticals Inc?

Luke Evnin is the 10 percent owner of EPIRUS Biopharmaceuticals Inc. Other key executives at EPIRUS Biopharmaceuticals Inc include Chief Business Officer Vincent Aurentz , Chief Financial Officer Thomas A. Shea , and director & Chief Executive Officer Amit Munshi .

EPIRUS Biopharmaceuticals Inc (EPRSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EPIRUS Biopharmaceuticals Inc (EPRSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

EPIRUS Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Altimmune Inc do?

Who are the key executives at Altimmune Inc?

Luke Evnin is the other: See explanation below of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Gregory L Weaver , Chief Medical Officer Christophe Arbet-engels , and Chief Commercial Officer Linda M Richardson .

Altimmune Inc (ALT) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net purchase of 47,500 shares made by Jerome Benedict Durso , a net purchase of 25,000 shares made by Gregory L Weaver , and a net purchase of 21,700 shares made by John Gill .

In summary, during the past 3 months, insiders sold 0 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Altimmune Inc (ALT) were sold and 101,227 shares were bought by its insiders, resulting in a net purchase of 101,227 shares.

Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Altimmune Inc Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

Luke Evnin is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Mark W Perry .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does AVEO Pharmaceuticals Inc do?

Who are the key executives at AVEO Pharmaceuticals Inc?

Luke Evnin is the 10 percent owner of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .

AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

AVEO Pharmaceuticals Inc Insider Transactions

No Available Data

What does Metabasis Therapeutics Inc do?

Who are the key executives at Metabasis Therapeutics Inc?

Luke Evnin is the director & 10 percent owner of Metabasis Therapeutics Inc. Other key executives at Metabasis Therapeutics Inc include 10 percent owner Ansbert Gadicke , 10 percent owner Michael Steinmetz , and 10 percent owner Mpm Asset Management Investors 2000b Llc .

Metabasis Therapeutics Inc (LGNZZ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Metabasis Therapeutics Inc (LGNZZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metabasis Therapeutics Inc (LGNZZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metabasis Therapeutics Inc (LGNZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Metabasis Therapeutics Inc Insider Transactions

No Available Data

What does Poniard Pharmaceuticals Inc do?

Who are the key executives at Poniard Pharmaceuticals Inc?

Luke Evnin is the 10 percent owner of Poniard Pharmaceuticals Inc. Other key executives at Poniard Pharmaceuticals Inc include President & CMO Michael S Perry , director & Chief Executive Officer Ron Martell , and director & 10 percent owner Simon Nicholas J Iii .

Poniard Pharmaceuticals Inc (PARD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Poniard Pharmaceuticals Inc (PARD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poniard Pharmaceuticals Inc (PARD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Poniard Pharmaceuticals Inc (PARD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Poniard Pharmaceuticals Inc Insider Transactions

No Available Data

What does T-Mobile US Inc do?

Who are the key executives at T-Mobile US Inc?

Luke Evnin is the 10 percent owner of T-Mobile US Inc. Other key executives at T-Mobile US Inc include EVP & Consumer Markets Jon Freier , EVP & T-Mobile for Business Michael J. Katz , and Chief Operating Officer G Michael Sievert .

T-Mobile US Inc (TMUS) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in T-Mobile US Inc (TMUS). Other recent insider transactions involving T-Mobile US Inc (TMUS) include a net sale of 6,148,777 shares made by Telekom Ag Deutsche , a net sale of 275,000 shares made by G Michael Sievert , and a net sale of 59,176 shares made by Mark Wolfe Nelson .

In summary, during the past 3 months, insiders sold 4,799 shares of T-Mobile US Inc (TMUS) in total and bought 0 shares, with a net sale of 4,799 shares. During the past 18 months, 7,174,788 shares of T-Mobile US Inc (TMUS) were sold and 14,897 shares were bought by its insiders, resulting in a net sale of 7,159,891 shares.

T-Mobile US Inc (TMUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

T-Mobile US Inc Insider Transactions

No Available Data

What does Affymax Inc do?

Who are the key executives at Affymax Inc?

Luke Evnin is the 10 percent owner of Affymax Inc. Other key executives at Affymax Inc include Chief Financial Officer Mark G Thompson , Chief Commercial Officer Jeffrey H Knapp , and Chief Financial Officer Herb Cross .

Affymax Inc (AFFY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Affymax Inc (AFFY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Affymax Inc (AFFY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Affymax Inc (AFFY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Affymax Inc Insider Transactions

No Available Data

What does Acorda Therapeutics Inc do?

Who are the key executives at Acorda Therapeutics Inc?

Luke Evnin is the 10 percent owner of Acorda Therapeutics Inc. Other key executives at Acorda Therapeutics Inc include CEO and President Ron Cohen , Chief Financial Officer Michael A Gesser , and General Counsel Neil S. Belloff .

Acorda Therapeutics Inc (ACORQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acorda Therapeutics Inc (ACORQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acorda Therapeutics Inc (ACORQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acorda Therapeutics Inc (ACORQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Acorda Therapeutics Inc Insider Transactions

No Available Data

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Luke Evnin is the 10 percent owner of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , EVP & GC & CCO & Corp Sec Raymond J. Furey , and director & CEO & President Raul R Rodriguez .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 5,000 shares made by Kamil Ali-jackson , and a net sale of 4,000 shares made by Walter H Moos .

In summary, during the past 3 months, insiders sold 5,000 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 5,000 shares. During the past 18 months, 9,000 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,000 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

What does Bio Green Med Solution Inc do?

Who are the key executives at Bio Green Med Solution Inc?

Luke Evnin is the 10 percent owner of Bio Green Med Solution Inc. Other key executives at Bio Green Med Solution Inc include 10 percent owner Kim Choy Yap , 10 percent owner Yee Lung Ong , and 10 percent owner Khai Loon Kua .

Bio Green Med Solution Inc (BGMS) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Bio Green Med Solution Inc (BGMS). Other recent insider transactions involving Bio Green Med Solution Inc (BGMS) include a net sale of 404,505 shares made by Kim Choy Yap , a net sale of 404,465 shares made by Khai Loon Kua , and a net sale of 277,910 shares made by Diversified Berhad Fitters .

In summary, during the past 3 months, insiders sold 0 shares of Bio Green Med Solution Inc (BGMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,309,049 shares of Bio Green Med Solution Inc (BGMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,309,049 shares.

Bio Green Med Solution Inc (BGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bio Green Med Solution Inc Insider Transactions

No Available Data

What does iPass Inc do?

Who are the key executives at iPass Inc?

Luke Evnin is the 10 percent owner of iPass Inc. Other key executives at iPass Inc include Senior VP and CFO Karen Willem , Senior VP and CFO Steven Gatoff , and Senior VP of Worldwide Sales Nicholas W Hulse .

iPass Inc (IPAS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of iPass Inc (IPAS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of iPass Inc (IPAS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

iPass Inc (IPAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

iPass Inc Insider Transactions

No Available Data

What does Entrada Therapeutics Inc do?

Who are the key executives at Entrada Therapeutics Inc?

Luke Evnin is the 10 percent owner of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include 10 percent owner 5am Ventures V, L.p. , director & 10 percent owner Kush Parmar , and Chief Scientific Officer Natarajan Sethuraman .

Entrada Therapeutics Inc (TRDA) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 37,659 shares made by Kory James Wentworth , a net sale of 468,474 shares made by 5am Ventures V, L.p. , and a net sale of 468,474 shares made by Kush Parmar .

In summary, during the past 3 months, insiders sold 232,948 shares of Entrada Therapeutics Inc (TRDA) in total and bought 5,000 shares, with a net sale of 227,948 shares. During the past 18 months, 1,030,524 shares of Entrada Therapeutics Inc (TRDA) were sold and 211,911 shares were bought by its insiders, resulting in a net sale of 818,613 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Entrada Therapeutics Inc Insider Transactions

No Available Data

What does Werewolf Therapeutics Inc do?

Who are the key executives at Werewolf Therapeutics Inc?

Luke Evnin is the director of Werewolf Therapeutics Inc. Other key executives at Werewolf Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , VP of Finance & Corp. Contr. Michael J. Urban , and 10 percent owner Mpm Bioventures 2014, L.p. .

Werewolf Therapeutics Inc (HOWL) Insider Trades Summary

Over the past 18 months, Luke Evnin made 31 insider transaction in Werewolf Therapeutics Inc (HOWL) with a net sale of 4,220,911. Other recent insider transactions involving Werewolf Therapeutics Inc (HOWL) include a net sale of 1,938,945 shares made by Mpm Oncology Innovations Fund Lp , a net sale of 1,641,479 shares made by Mpm Bioventures 2014, L.p. , and a net sale of 1,572,714 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 3,687,889 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 3,687,889 shares. During the past 18 months, 9,910,475 shares of Werewolf Therapeutics Inc (HOWL) were sold and 536,426 shares were bought by its insiders, resulting in a net sale of 9,374,049 shares.

Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Werewolf Therapeutics Inc Insider Transactions

No Available Data

What does Turmeric Acquisition Corp do?

Who are the key executives at Turmeric Acquisition Corp?

Turmeric Acquisition Corp (TMPM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Turmeric Acquisition Corp (TMPM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turmeric Acquisition Corp (TMPM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turmeric Acquisition Corp (TMPM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Turmeric Acquisition Corp Insider Transactions

No Available Data

What does Aktis Oncology Inc do?

Who are the key executives at Aktis Oncology Inc?

Luke Evnin is the 10 percent owner of Aktis Oncology Inc. Other key executives at Aktis Oncology Inc include Chief Medical Officer Akos Czibere , Chief Operating Officer Shulamit Ron-bigger , and 10 percent owner Eli Lilly & Co .

Aktis Oncology Inc (AKTS) Insider Trades Summary

Over the past 18 months, Luke Evnin made no insider transaction in Aktis Oncology Inc (AKTS). Other recent insider transactions involving Aktis Oncology Inc (AKTS) include a net sale of 7,921 shares made by Ken Herrmann , a net purchase of 2,222,222 shares made by Ecor1 Capital, Llc , and a net purchase of 1,112,777 shares made by Mpm Bioventures 2018, L.p. .

In summary, during the past 3 months, insiders sold 107,921 shares of Aktis Oncology Inc (AKTS) in total and bought 0 shares, with a net sale of 107,921 shares. During the past 18 months, 107,921 shares of Aktis Oncology Inc (AKTS) were sold and 6,350,646 shares were bought by its insiders, resulting in a net purchase of 6,242,725 shares.

Aktis Oncology Inc (AKTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aktis Oncology Inc Insider Transactions

No Available Data

Luke Evnin Mailing Address

Above is the net worth, insider trading, and ownership report for Luke Evnin. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Luke Evnin's mailing address is: Boston Ma 02116.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.